BioSpace News Archive

Business

Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases.

July 12, 2021
·
2 min read
Universal PropTech Grows Backlog to Approximately $6 Million

Universal PropTech Inc. (TSXV: UPI) (OTCQB: UPIPF) (FSE: 8LH) (“UPI” or the “Company”) is pleased to announce an update on the Company’s backlog of awarded and not executed work, made up of a combination of service contracts and project work in both HVAC Building Automation and Mechanical lines of business.

July 12, 2021
·
3 min read
Business

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021

Adaptive Biotechnologies Corporation today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021.

July 12, 2021
·
1 min read
Drug Development

Equillium Announces Plans to Initiate Phase 3 Pivotal Study of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease Following End-of-Phase 1 Meeting with the FDA

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced the completion of an End-of-Phase 1 meeting with the U.S. Food and Drug Administration (FDA) for itolizumab in first-line treatment of patients with acute graft-versus-host disease (aGVHD)

July 12, 2021
·
6 min read
BioForest

Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021

Chinook Therapeutics, Inc. today announced that Chinook management is scheduled to participate in a virtual fireside chat at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 12:00 pm ET.

July 12, 2021
·
1 min read
Business

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

Apyx Medical Corporation today announced that financial results for the second quarter of fiscal year 2021 will be released before the market opens on Thursday, August 12th.

July 12, 2021
·
2 min read
Business

Tandem Diabetes Care to Announce Second Quarter 2021 Financial Results on August 4, 2021

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its second quarter 2021 results after the financial markets close on Wednesday, August 4, 2021.

July 12, 2021
·
1 min read
Pharm Country

IVERIC bio, Inc. Announces Proposed Offering of Common Stock - July 12, 2021

IVERIC bio, Inc., announced that it is commencing an underwritten public offering of shares of its common stock.

July 12, 2021
·
5 min read
Increase in Prevalence of Chronic Diseases to Spike the Growth of the Global Active Pharmaceutical Ingredients Market

Drug products (e.g. tablets, capsules) are generally composed of numerous components, Active Pharmaceutical Ingredient (API) being the primary ingredient.

July 12, 2021
·
3 min read
Infectious Disease Therapeutics Market to hit big due to Rising Clinical Trials for the Development of New Drugs

Infectious diseases are caused by various pathogenic organisms like parasites, viruses, and bacteria.

July 12, 2021
·
4 min read